Lepzi is an innovative ground for development of high performance technologies for point-of-care medical diagnostics. The LEPZI assay platform developed by our team enables fast, simple and reliable point-of-care testing while addressing the demand for accessible and cost- effective healthcare.

Lepzi Biotechnology Ltd.,based in Richmond, Canada.Our team brings together professionals with extensive experience in design and development of point-of-care medical devices, from early-stage prototyping and reagent development to implementation of specialized manufacturing and quality control processes.

Lepzi Diagnostika Ltd., based in Sofia, Bulgaria.We are innovative company working in the field of high-performance technologies for medical diagnostics and medical care. Our team consists of professionals with extensive experience in the design and development of medical devices, prototypes and reagents to the application of specialized processes for production and quality control. Lepzi Diagnostika provides an advanced platform for immunoassay that allows a rapid flow of diagnostic information for improvement of the medical care.

We strongly believe that quality by design and a solid quality management system coupled with compliance to all applicable standards will contribute to the success of our products.

Our Quality Management System is ISO 13485:2016 registered and it creates a reliable framework for development and manufacture of critical assay components for the LEPZI platform.

Lepzi has got CE marking. As the manufacturer,Lepzi is now responsible for the design, manufacture and control of the registered medical device (s) and its assessment in accordance with the essential requirements of the Medical Devices Act and its implementing acts, which introduce Directive 98/79 / EC and other relevant regulations.

In line with our mission to become a global player in the field of point-of-care testing, Lepzi seeks opportunities for cooperation with partners who share our vision for innovation and technological advancements in the field of clinical diagnostics.

Our philosophy is that the challenges faced by the healthcare providers worldwide can only be solved by bringing together partners with a diverse expertise in biomarker discovery, clinical research, product development, manufacturing and commercialization.

We envision partnership opportunities in the following areas:

LEPZI assay platform licencing to facilitate the introduction of novel biomarkers for medical diagnostics.

Distribution partnerships to facilitate the introduction of reliable and cost- effective diagnostic solutions in different parts of the world.

Cooperation in building global manufacturing capabilities to address the unique demands of each market.